G1 Therapeutics Inc (GTHX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

700 PARK OFFICES DRIVE RESEARCH TRIANGLE PARK, NC 27709

G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company's first commercial product, COSELAâ„¢ (trilaciclib). G1 has a deep clinical pipeline evaluating targeted cancer therapies in a variety of solid tumors, including colorectal, breast, lung, and bladder cancers. G1 Therapeutics is based in Research Triangle Park, N.C.

Data as of 2021-07-25 17:29:38 -0400
Market Cap743.454 Million Shares Outstanding42.074 Million Avg 30-day Volume1.482 Million
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.42 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.41743 52-week High/Low37.07 / 10.81 Next Earnings Date2021-08-04 Price to Cash FLow (P/CF) -34.8185
Data provided by IEX Cloud
View SEC Filings from GTHX instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 1 0.0% 1 (0.06%) 1 (0.06%) 0.0%
Funds Holding: 123 127 -3.15% 32 (1.88%) 42 (2.44%) -23.81%
13F shares: 24.161 Million 24.135 Million 0.11% 6.145 Million 7.613 Million -19.28%
% Ownership 63.5053 63.4376 0.11% 16.1517 20.0097 -19.28%
New Positions: 23 17 35.29% 6 8 -25.0%
Increased Positions 43 47 -8.51% 12 10 20.0%
Closed Positions 25 10 150.0% 16 5 220.0%
Reduced Positions 36 43 -16.28% 10 20 -50.0%
Total Calls 449.945 Thousand 130.616 Thousand 244.48% 59.5 Thousand 53 Thousand 12.26%
Total Puts 518.17 Thousand 387.407 Thousand 33.75% 45.4 Thousand 105.7 Thousand -57.05%
PUT/CALL Ratio 1.15 2.97 -61.28% 0.76 1.99 -61.81%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding GTHX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GTHX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

70 Thousand total shares from 7 transactions

Exercise Derivative Conversion (M)

70 Thousand total shares from 8 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

VELLECA MARK A.

894,858 2021-07-13 8

RUDNICK SETH

9,655 2021-06-29 6

MUIR GLENN P

194,978 2021-06-17 2

DEESE WILLIE A

24,009 2021-06-17 1

SCHWALM CYNTHIA

25,509 2021-06-17 1

NICHOLSON GARRY A

24,009 2021-06-17 1

SECOR ALICIA

0 2021-06-17 2

MALIK RAJESH CHIEF MEDICAL OFFICER

118,300 2021-05-10 8

MOSES JENNIFER K. CFO

25,333 2021-03-03 2

MURDOCK TERRY L CHIEF OPERATING OFFICER

  • Officer
11,000 2021-01-04 1

HANSON JAMES S. GENERAL COUNSEL

  • Officer
15,000 2021-01-04 2

AVAGLIANO MARK CHIEF BUSINESS OFFICER

  • Officer
11,000 2021-01-04 1

GUPTA SOMA CHIEF COMMERCIAL OFFICER

  • Officer
11,000 2021-01-04 1

BAILEY JOHN E. (JACK) JR. PRESIDENT AND CEO

  • Officer
  • Director
221,333 2021-01-01 2

ESHELMAN FREDRIC N

  • Director
0 2020-06-11 0

DEMAREE JOHN CHIEF COMMERCIAL OFFICER

0 2020-02-06 0

WITTY ANDREW

  • Director
0 2019-06-12 0

STRUM JAY CHIEF SCIENTIFIC OFFICER

129,237 2019-01-02 0

PHILLIPS BARCLAY A SVP & CHIEF FINANCIAL OFFICER

0 2019-01-02 0

THORP CLAY

HATTERAS VENTURE ADVISORS IV SBIC, LLC

HATTERAS VENTURE PARTNERS IV SBIC, LP

INGRAM ROBERT ALEXANDER

CRUMPLER JOHN

LEE KENNETH B JR

REED DOUGLAS MD

  • 10% Owner
3,237,711 2018-05-30 0

MEDIMMUNE VENTURES, INC.

  • 10% Owner
2,950,630 2017-12-15 0

SHAFFER CHRISTY L

  • Director
995 2017-11-30 0

RA CAPITAL MANAGEMENT, LLC

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

  • FMR 10% OWNER SEE FOOTNOTE (2)FMR 10% OWNER SEE FOOTNOTE (2)FMR 10% OWNER SEE FOOTNOTE (2)
No longer subject to file 2017-05-22 0

ESHELMAN VENTURES, LLC

  • 10% Owner
3,439,151 2017-05-22 0

MOSSINGHOFF GREGORY J CHIEF BUSINESS OFFICER

  • Officer
0 2017-05-16 0

RIVERS TYRELL

  • Director
0 2017-05-16 0

THORP CLAY

  • 10% Owner
213,114 2017-05-16 0

ESHELMAN FREDRIC N

ESHELMAN VENTURES, LLC

  • Director
  • 10% Owner
0 2017-05-16 0

SULLIVAN TIMOTHY EUGENE

  • Director
0 2017-05-16 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

VELLECA MARK A.

2021-07-15 16:01:39 -0400 2021-07-15 M 10,000 $0.39 a 71,000 direct -5.7113 -6.5574 0.0 1 -6.5574 6

VELLECA MARK A.

2021-07-15 16:01:39 -0400 2021-07-15 M 10,000 d 227,286 direct

VELLECA MARK A.

2021-07-15 16:01:39 -0400 2021-07-15 S 10,000 $18.49 d 61,000 direct yes -5.7113 -6.5574 0.0 1 -6.5574 6

VELLECA MARK A.

2021-07-15 16:01:39 -0400 2021-07-14 M 10,000 d 237,286 direct

VELLECA MARK A.

2021-07-15 16:01:39 -0400 2021-07-14 S 10,000 $19.08 d 61,000 direct yes -5.7113 -6.5574 0.0 1 -6.5574 6

VELLECA MARK A.

2021-07-15 16:01:39 -0400 2021-07-14 M 10,000 $0.39 a 71,000 direct -5.7113 -6.5574 0.0 1 -6.5574 6

VELLECA MARK A.

2021-07-15 16:01:39 -0400 2021-07-13 S 10,000 $19.45 d 61,000 direct yes -5.7113 -6.5574 0.0 1 -6.5574 6

VELLECA MARK A.

2021-07-15 16:01:39 -0400 2021-07-13 M 10,000 d 247,286 direct

VELLECA MARK A.

2021-07-15 16:01:39 -0400 2021-07-13 M 10,000 $0.39 a 71,000 direct -5.7113 -6.5574 0.0 1 -6.5574 6

RUDNICK SETH

2021-06-30 16:05:05 -0400 2021-06-29 M 2,031 d 11,859 direct

RUDNICK SETH

2021-06-30 16:05:05 -0400 2021-06-29 M 7,969 $0.39 a 12,358 direct -4.5839 -8.6337 0.0 1 -10.9479 4

RUDNICK SETH

2021-06-30 16:05:05 -0400 2021-06-29 S 10,000 $22.35 d 4,389 direct yes -4.5839 -8.6337 0.0 1 -10.9479 4

RUDNICK SETH

2021-06-30 16:05:05 -0400 2021-06-29 M 7,969 d 0 direct

RUDNICK SETH

2021-06-30 16:05:05 -0400 2021-06-29 M 2,031 $0.30 a 14,389 direct -4.5839 -8.6337 0.0 1 -10.9479 4

SCHWALM CYNTHIA

2021-06-21 16:25:01 -0400 2021-06-17 A 19,620 a 19,620 direct

DEESE WILLIE A

2021-06-21 16:05:41 -0400 2021-06-17 A 19,620 a 19,620 direct

RUDNICK SETH

2021-06-21 16:06:07 -0400 2021-06-17 A 4,389 a 4,389 direct 2.2472 5.8521 12.2659 4 0.0 1

VELLECA MARK A.

2021-06-17 16:05:43 -0400 2021-06-17 M 10,000 d 257,286 direct

VELLECA MARK A.

2021-06-17 16:05:43 -0400 2021-06-17 S 10,000 $21.77 d 61,000 direct yes 2.7685 14.463 14.463 6 0.0 1

NICHOLSON GARRY A

2021-06-21 16:06:00 -0400 2021-06-17 A 19,620 a 19,620 direct

SCHWALM CYNTHIA

2021-06-21 16:25:01 -0400 2021-06-17 A 4,389 a 5,889 direct 2.2472 5.8521 12.2659 4 0.0 1

DEESE WILLIE A

2021-06-21 16:05:41 -0400 2021-06-17 A 4,389 a 4,389 direct 2.2472 5.8521 12.2659 4 0.0 1

MUIR GLENN P

2021-06-21 16:05:54 -0400 2021-06-17 A 19,620 a 19,620 direct

VELLECA MARK A.

2021-06-17 16:05:43 -0400 2021-06-17 M 10,000 $0.39 a 71,000 direct 2.7685 14.463 14.463 6 0.0 1

NICHOLSON GARRY A

2021-06-21 16:06:00 -0400 2021-06-17 A 4,389 a 4,389 direct 2.2472 5.8521 12.2659 4 0.0 1

SECOR ALICIA

2021-06-21 16:45:03 -0400 2021-06-17 A 52,320 a 52,320 direct

RUDNICK SETH

2021-06-21 16:06:07 -0400 2021-06-17 A 19,620 a 19,620 direct

MUIR GLENN P

2021-06-21 16:05:54 -0400 2021-06-17 A 4,389 a 175,358 direct 2.2472 5.8521 12.2659 4 0.0 1

VELLECA MARK A.

2021-06-17 16:05:43 -0400 2021-06-16 M 10,000 $0.39 a 71,000 direct 2.7685 14.463 14.463 6 0.0 1

VELLECA MARK A.

2021-06-17 16:05:43 -0400 2021-06-16 M 10,000 d 267,286 direct

VELLECA MARK A.

2021-06-17 16:05:43 -0400 2021-06-16 S 10,000 $21.74 d 61,000 direct yes 2.7685 14.463 14.463 6 0.0 1

VELLECA MARK A.

2021-06-17 16:05:43 -0400 2021-06-15 M 10,000 $0.39 a 71,000 direct 2.7685 14.463 14.463 6 0.0 1

VELLECA MARK A.

2021-06-17 16:05:43 -0400 2021-06-15 S 10,000 $22.39 d 61,000 direct yes 2.7685 14.463 14.463 6 0.0 1

VELLECA MARK A.

2021-06-17 16:05:43 -0400 2021-06-15 M 10,000 d 277,286 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
G1 THERAPEUTICS INC GTHX 2021-07-28 18:15:03 UTC -0.2863 0.3663 500000
G1 THERAPEUTICS INC GTHX 2021-07-28 17:45:03 UTC -0.2863 0.3663 500000
G1 THERAPEUTICS INC GTHX 2021-07-28 17:15:03 UTC -0.2863 0.3663 500000
G1 THERAPEUTICS INC GTHX 2021-07-28 16:45:03 UTC -0.2473 0.3273 500000
G1 THERAPEUTICS INC GTHX 2021-07-28 16:15:02 UTC -0.2473 0.3273 500000
G1 THERAPEUTICS INC GTHX 2021-07-28 15:45:03 UTC -0.2473 0.3273 550000
G1 THERAPEUTICS INC GTHX 2021-07-28 15:15:03 UTC -0.2473 0.3273 550000
G1 THERAPEUTICS INC GTHX 2021-07-28 14:45:02 UTC -0.2001 0.2801 550000
G1 THERAPEUTICS INC GTHX 2021-07-28 14:15:03 UTC -0.2001 0.2801 500000
G1 THERAPEUTICS INC GTHX 2021-07-28 13:45:02 UTC -0.2001 0.2801 500000
G1 THERAPEUTICS INC GTHX 2021-07-28 13:15:03 UTC -0.2001 0.2801 500000
G1 THERAPEUTICS INC GTHX 2021-07-28 12:45:03 UTC -0.2001 0.2801 500000
G1 THERAPEUTICS INC GTHX 2021-07-27 22:15:03 UTC -0.2001 0.2801 550000
G1 THERAPEUTICS INC GTHX 2021-07-27 21:45:03 UTC -0.2001 0.2801 550000
G1 THERAPEUTICS INC GTHX 2021-07-27 21:15:03 UTC -0.2001 0.2801 550000
G1 THERAPEUTICS INC GTHX 2021-07-27 20:45:03 UTC -0.1824 0.2624 550000
G1 THERAPEUTICS INC GTHX 2021-07-27 20:15:03 UTC -0.1824 0.2624 550000
G1 THERAPEUTICS INC GTHX 2021-07-27 19:45:02 UTC -0.1824 0.2624 550000
G1 THERAPEUTICS INC GTHX 2021-07-27 19:15:02 UTC -0.1824 0.2624 550000
G1 THERAPEUTICS INC GTHX 2021-07-27 18:45:03 UTC -0.1846 0.2646 550000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund GTHX -30.0 shares, $-330.6 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund GTHX -44.0 shares, $-484.88 2020-03-31 N-PORT

Elevate your investments